Revisiting rodent models: Octodon degus as Alzheimer’s disease model?
Open accessAbstract
Alzheimer's disease primarily occurs as sporadic disease and is accompanied with vast socio-economic problems. The mandatory basic research relies on robust and reliable disease models to overcome increasing incidence and emerging social challenges. Rodent models are most efficient, versatile, and predominantly used in research. However, only highly artificial and mostly genetically modified models are available. As these 'engineered' models reproduce only isolated features, researchers demand more suitable models of sporadic neurodegenerative diseases. One very promising animal model was the South American rodent Octodon degus, which was repeatedly described as natural 'sporadic Alzheimer's disease model' with 'Alzheimer's disease-like neuropathology'. To unveil advantages over the 'artificial' mouse models, we re-evaluated the age-dependent, neurohistological changes in young and aged Octodon degus (1 to 5-years-old) bred in a wild-type colony in Germany. In our hands, extensive neuropathological analyses of young and aged animals revealed normal age-related cortical changes without obvious signs for extensive degeneration as seen in patients with dementia. Neither significant neuronal loss nor enhanced microglial activation were observed in aged animals. Silver impregnation methods, conventional, and immunohistological stains as well as biochemical fractionations revealed neither amyloid accumulation nor tangle formation. Phosphoepitope-specific antibodies against tau species displayed similar intraneuronal reactivity in both, young and aged Octodon degus.In contrast to previous results, our study suggests that Octodon degus born and bred in captivity do not inevitably develop cortical amyloidosis, tangle formation or neuronal loss as seen in Alzheimer's disease patients or transgenic disease models.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Octodon degu AD-associated pathology appears inconsistent as other studies do report any AD associated pathology in aged animals.
“However this pathology appears to be inconsistent as other studies do report any AD associated pathology in aged animals [149].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 61 · Cited by 62
- Authors
- Steffen, J., Krohn, M., Paarmann, K., Schwitlick, C., Brüning, T., Marreiros, R., Müller-Schiffmann, A., Korth, C., Braun, K., & Pahnke, J.
- Affiliations
- University of Lübeck (DE)
- Oslo University Hospital (NO)
- Heinrich Heine University Düsseldorf (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Corresponding author
- Pahnke, Jens
- Venue
- Acta Neuropathologica Communications
- Published
- 2016-08-26
- Volume
- 4
- Issue
- 1
- Pages
- 91-91
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC5002178
- OpenAlex
- W2513378585
- Cited by
- 62
- References
- 61
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 1
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- Bundesministerium für Bildung und Forschung (UBICA, TRANS-GEN)
- Deutsche Forschungsgemeinschaft (DFG930/9, DFG930/12)
- Norges Forskningsråd (NFR247179, NFR260786)
- VIAA Latvia (NFI/R/2014/023)
- Leibniz-Gemeinschaft (SAW-2015-IPB-2)
- Helse Sør-Øst RHF (2016062)
- German-Israeli Foundation for Scientific Research and Development
- EU FP7 (MC-ITN IN-SENS #607616))
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Octodon degus, Alzheimer's disease, animal models of dementia, amyloid accumulation, neurofibrillary tangles, tau phosphorylation, microglial activation, neuronal loss
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Humans, Immunohistochemistry, Male, Mice, Transgenic, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Octodon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review